ArticlePain2026
Fear-induced hyperalgesia in quiescent inflammatory bowel disease.
Article in Pain, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Psychological adaptation and health-related quality of life in inflammatory bowel disease: a 5-year follow-up study.Research in psychotherapy (Milano) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
abstractRecurring pain is a debilitating symptom in inflammatory bowel disease (IBD), often persisting beyond acute gut inflammation with unclear underlying mechanisms. Altered emotional reactivity to pain has been proposed as a key contributor to pain persistence, but experimental evidence is scarce. This study investigated whether pain-related fear learning shapes the perception of acute experimental pain in quiescent IBD. Implementing a 2-day differential fear conditioning paradigm, we assessed the acquisition and extinction of conditioned fear in response to nociceptive (thermal pain) and non-nociceptive (aversive tones) unconditioned stimuli (US) in IBD patients and healthy controls. After overnight consolidation, US re-exposure was evaluated, focusing on pain intensity and unpleasantness ratings. Compared with healthy volunteers, IBD patients exhibited significantly enhanced pain intensity and unpleasantness upon re-exposure to pain, correlating with the magnitude of pain-related fear learning the day before. The relationship between fear learning and pain intensity was fully mediated by pain unpleasantness, suggesting a key role of the emotional valence of pain. Notably, behavioral measures of fear acquisition and extinction were unaltered in patients, pointing toward pain-related central adaptations rather than exaggerated fear acquisition as the underlying mechanism. These findings identify fear-induced hyperalgesia as a potential central mechanism contributing to persistent pain in IBD and highlight the importance of targeting conditioned fear in future personalized interventions to fill the current therapeutic gap in IBD-related pain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.